GL1X · GenesisL1 explorer

MolNFT v1 · #157931 · protein

VAV1 inhibited by an allosteric inhibitor: VAV1 inhibitors block gef activity

6NF1 · Proto-oncogene vav: “VAV1 inhibited by an allosteric inhibitor: VAV1 inhibitors block gef activity”. X-ray diffraction, 2 ligands (9JY, ZN), 3 pockets (best druggability 0.75). MolNFT v1 #157931 on GenesisL1: 3D structure, binding…

PDB
6NF1
Type
protein
Length
550 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene vav
UniProt
P15498
Ligands
9JY, ZN
Pockets
3 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 54% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene vavprotein55054% helix, 12% strandP15498

Ligands and binding sites

  • 9JY · (2S)-3-[(3S)-1-(ethylsulfonyl)piperidin-3-yl]-2-{[3-(4-methylphenyl)imidazo[1,2-a]pyrazin-8-yl]amino}propan-1-ol · ligand · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13750.750.8644empty
29260.730.7784MES
31420.590.83249JY

Compared structures

  • 6NF1 · Vav1 inhibited by an allosteric inhibitor: Vav1 inhibitors block GEF activity · the same entry in another collection · chain A against A, TM-score 1.00
  • P15498 · AlphaFold monomer V2.0 prediction for proto-oncogene vav (P15498) · a predicted model of the same protein · chain A against A, TM-score 0.90

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.